Diane Flynn1, Ardith Z Doorenbos2, Alana Steffen3, Honor McQuinn1, Dale J Langford4. 1. Madigan Army Medical Center, Tacoma, Washington. 2. Departments of Biobehavioral Health Science. 3. Health Systems Science, College of Nursing, University of Illinois at Chicago, Chicago, Illinois. 4. Department of Anesthesiology & Pain Medicine, School of Medicine, University of Washington, Seattle, Washington, USA.
Abstract
OBJECTIVE: Benefits of primary care provider (PCP) participation in pain management telementoring have been reported; however, no studies have examined within-patient changes in dose or discontinuation of long-term opioid therapy (LOT). The objectives of this nonrandomized study were to evaluate the relationship between telementoring participation and 1) LOT dose reduction and 2) LOT discontinuation and to 3) explore the relationship between LOT dose changes and patient-reported outcomes. METHODS: PCPs were recruited from a US Army medical center. Intervention group PCPs (N = 12) attended telementoring sessions; control group providers (N = 13) did not. Morphine equivalent daily doses (MEDD) for patients of study providers (N = 396) were extracted from the study site's opioid database. The intervention group was subdivided based on number of sessions attended (i.e., active and low participation). Intent-to-treat and as-treated analyses were conducted using generalized estimating equations. Separate analyses evaluated the association between within-patient changes in MEDD and pain impact, depression, and anxiety (N = 40). RESULTS: Intent-to-treat analysis revealed no significant difference in MEDD reduction; however, a higher proportion of patients of intervention PCPs discontinued LOT (25% ± 3.6%) compared with control PCPs (16% ± 3.6%, P < 0.05). As-treated analyses revealed differences in MEDD reduction between active (13.2 ± 3.0) and low-participating (2.6 ± 3.0) PCPs (P < 0.01). Further, a higher proportion of patients of actively participating PCPs discontinued LOT (29% ± 4.9%) compared with control PCPs (16% ± 3.6%, P = 0.01). We found no evidence that decreased MEDD was associated with poorer self-reported outcomes within patients. CONCLUSIONS: Pain management telementoring supports PCPs' efforts to reduce reliance on LOT for chronic pain management and highlights the need for actively engaged PCP pain champions.
OBJECTIVE: Benefits of primary care provider (PCP) participation in pain management telementoring have been reported; however, no studies have examined within-patient changes in dose or discontinuation of long-term opioid therapy (LOT). The objectives of this nonrandomized study were to evaluate the relationship between telementoring participation and 1) LOT dose reduction and 2) LOT discontinuation and to 3) explore the relationship between LOT dose changes and patient-reported outcomes. METHODS: PCPs were recruited from a US Army medical center. Intervention group PCPs (N = 12) attended telementoring sessions; control group providers (N = 13) did not. Morphine equivalent daily doses (MEDD) for patients of study providers (N = 396) were extracted from the study site's opioid database. The intervention group was subdivided based on number of sessions attended (i.e., active and low participation). Intent-to-treat and as-treated analyses were conducted using generalized estimating equations. Separate analyses evaluated the association between within-patient changes in MEDD and pain impact, depression, and anxiety (N = 40). RESULTS: Intent-to-treat analysis revealed no significant difference in MEDD reduction; however, a higher proportion of patients of intervention PCPs discontinued LOT (25% ± 3.6%) compared with control PCPs (16% ± 3.6%, P < 0.05). As-treated analyses revealed differences in MEDD reduction between active (13.2 ± 3.0) and low-participating (2.6 ± 3.0) PCPs (P < 0.01). Further, a higher proportion of patients of actively participating PCPs discontinued LOT (29% ± 4.9%) compared with control PCPs (16% ± 3.6%, P = 0.01). We found no evidence that decreased MEDD was associated with poorer self-reported outcomes within patients. CONCLUSIONS:Pain management telementoring supports PCPs' efforts to reduce reliance on LOT for chronic pain management and highlights the need for actively engaged PCP pain champions.
Authors: Richard A Deyo; Samuel F Dworkin; Dagmar Amtmann; Gunnar Andersson; David Borenstein; Eugene Carragee; John Carrino; Roger Chou; Karon Cook; Anthony DeLitto; Christine Goertz; Partap Khalsa; John Loeser; Sean Mackey; James Panagis; James Rainville; Tor Tosteson; Dennis Turk; Michael Von Korff; Debra K Weiner Journal: Pain Med Date: 2014-08 Impact factor: 3.750
Authors: Sanjeev Arora; Cynthia M A Geppert; Summers Kalishman; Denise Dion; Frank Pullara; Barbara Bjeletich; Gary Simpson; Dale C Alverson; Lori B Moore; Dave Kuhl; Joseph V Scaletti Journal: Acad Med Date: 2007-02 Impact factor: 6.893
Authors: Dagmar Amtmann; Karon F Cook; Mark P Jensen; Wen-Hung Chen; Seung Choi; Dennis Revicki; David Cella; Nan Rothrock; Francis Keefe; Leigh Callahan; Jin-Shei Lai Journal: Pain Date: 2010-07 Impact factor: 6.961
Authors: Ardith Z Doorenbos; Deborah B Gordon; David Tauben; Jenny Palisoc; Mark Drangsholt; Taryn Lindhorst; Jennifer Danielson; June Spector; Ruth Ballweg; Linda Vorvick; John D Loeser Journal: J Pain Date: 2013-10-04 Impact factor: 5.820
Authors: Matthias Rose; Jakob B Bjorner; Barbara Gandek; Bonnie Bruce; James F Fries; John E Ware Journal: J Clin Epidemiol Date: 2014-05 Impact factor: 6.437
Authors: Chester C Buckenmaier; Kevin T Galloway; Rosemary C Polomano; Mary McDuffie; Nancy Kwon; Rollin M Gallagher Journal: Pain Med Date: 2012-11-08 Impact factor: 3.750
Authors: David J Tauben; Dale J Langford; John A Sturgeon; Sean D Rundell; Cara Towle; Christina Bockman; Michael Nicholas Journal: Pain Date: 2020-11 Impact factor: 6.961